Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 30, 2015 16:01 ET | Source: CareDx, Inc.

Key Opinion Leaders to Present Data on Cell-Free DNA (cfDNA) Biomarker in Transplant Recipients at 2015 American Transplant Congress

BRISBANE, Calif., April 30, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high...
April 16, 2015 11:00 ET | Source: CareDx, Inc.

CareDx Cell-Free DNA (cfDNA) Biomarker in Combination With AlloMap(R) Increases Accuracy of Identification of Rejection in Heart Transplant Recipients

BRISBANE, Calif. and NICE, France, April 16, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the development and commercialization of clinically...
April 08, 2015 16:05 ET | Source: CareDx, Inc.

CareDx to Present New Data on AlloMap(R) and Cell-Free DNA (cfDNA) Biomarker in Heart Transplant Recipients at ISHLT 2015

BRISBANE, Calif., April 8, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high...
March 17, 2015 16:05 ET | Source: CareDx, Inc.

CareDx, Inc. Reports Fourth Quarter and Full Year 2014 Financial Results

BRISBANE, Calif., March 17, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high...
March 03, 2015 16:05 ET | Source: CareDx, Inc.

CareDx to Release Fourth Quarter 2014 Financial Results and Host Conference Call on March 17, 2015

BRISBANE, Calif., March 3, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high...
March 03, 2015 16:05 ET | Source: CareDx, Inc.

CareDx Appoints William A. Hagstrom to Its Board of Directors

BRISBANE, Calif., March 3, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high...
February 05, 2015 08:05 ET | Source: CareDx, Inc.

CareDx to Present at Upcoming Investor Conferences

BRISBANE, Calif., Feb. 5, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high...
February 03, 2015 16:08 ET | Source: CareDx, Inc.

CareDx Secures $20 Million Term Loan With East West Bank, Replacing Existing Credit Facility

BRISBANE, Calif., Feb. 3, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high...
January 12, 2015 08:05 ET | Source: CareDx, Inc.

CareDx Announces Its Commercial European Partner Diaxonhit Has Selected Strasbourg University Hospital to Perform AlloMap(R) Testing in Europe

BRISBANE, Calif., Jan. 12, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high...
January 07, 2015 08:00 ET | Source: CareDx, Inc.

CareDx Receives Positive Coverage Decision for AlloMap(R) From Two Additional Medicare Administrative Carrier Jurisdictions

BRISBANE, Calif., Jan. 7, 2015 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the development and commercialization of clinically differentiated, high...